Harvard Task Force

The Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries (GTF.CCC) is a task force composed of 32 members, and brings together leaders from the cancer and global health communities.
 
Since 2010, HRH Princess Dina Mired has served as Honorary Co-President of the GTF.CCC. The GTF.CCC is a research and advisory initiative promoted by the Dana Farber Cancer Institute, the Harvard Global Equity Initiative, the Harvard Medical School and the Harvard School of Public Health to address the global burden of cancer in developing countries and advocate for expanding cancer care in those countries.
 
What the Harvard Global Task Force does
The mandate of the GTF.CCC is to design, implement and evaluate innovative strategies for expanding access to cancer prevention, detection and care in the developing world. The initiative focuses on the creation of global facilities and strategies for the financing and procurement of affordable, essential cancer drugs, vaccines and services for prevention, diagnosis, treatment, survivorship and palliation. Through local partners, the GTF.CCC supports implementation of innovative service delivery models that provide evidence for scaling up access to cancer care and control, and strengthening health systems in developing countries.
 
Closing the Cancer Divide Report (2011)
On October 28th, 2011, the GTF.CCC held an international conference in Boston at Harvard University in order to launch the GTF.CCC report “Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries” and present its findings, to develop a road-map for action on cancer care and control, and to implement report recommendations through multi-stakeholder engagement. This event followed on the strategies from the UN High-level Meeting on Prevention and Control of Non-communicable Diseases (September 19-20, 2011).
 
Download and read the full report by visiting this link: http://gtfccc.harvard.edu/icb/icb.do